Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Text Message Treatment for Social Anxiety

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03562650
Recruitment Status : Completed
First Posted : June 19, 2018
Last Update Posted : January 29, 2021
Sponsor:
Information provided by (Responsible Party):
Jesse Cougle, Florida State University

Brief Summary:
This is an intervention study designed to evaluate a text message based safety behavior fading treatment for people with social anxiety disorder.

Condition or disease Intervention/treatment Phase
Social Anxiety Behavioral: Safety Behavior Fading Behavioral: Present Centered Not Applicable

Detailed Description:
This study hopes to assess whether a month long text message based safety behavior fading protocol is effective in reducing safety behaviors and social anxiety symptoms. Over the course of four consecutive weeks, text messages will be sent to participants the first day of the study and every other day for four weeks (14 texts in total). These text messages will remind participants to either avoid using their three most engaged in safety behaviors (assessed at pre-treatment) or to stay present-focused. The past week frequency of the participants' safety behaviors will be assessed at the beginning of pre-treatment, post-treatment, and four week follow up assessments Participants will be asked to complete an additional online questionnaire for both a post-treatment and a 4-week post-treatment follow up assessment. We hypothesize that: 1) the safety behavior group will show a greater overall reduction in social anxiety symptoms, 2) that the safety behavior group will show a reduction in the frequency of safety behavior use, and 3) that the present-focused group will show an increase in mindfulness.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 97 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Active treatment and active treatment control conditions.
Masking: Single (Participant)
Masking Description: All participants are assigned to a condition and given a treatment justification, but are not told whether they are in the treatment or control condition.
Primary Purpose: Treatment
Official Title: Computerized Treatment for Social Anxiety
Actual Study Start Date : January 27, 2018
Actual Primary Completion Date : March 27, 2019
Actual Study Completion Date : March 27, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety Safety

Arm Intervention/treatment
Experimental: Safety Behavior Fading
Participants are asked to pick their three most common safety behaviors from a list and then receive texts every other day for a month reminding them to fade those behaviors.
Behavioral: Safety Behavior Fading
Participants are asked to fade their three most common safety behaviors associated with their social anxiety

Active Comparator: Present Centered
Participants receive texts every other day for a month asking them to try to focus on the present that day.
Behavioral: Present Centered
Participants are asked to try to increase their focus on the present.




Primary Outcome Measures :
  1. Social Phobia Inventory (SPIN) [ Time Frame: Change in social anxiety symptoms from baseline to post treatment (4 weeks) and one month follow up (8 weeks) ]
    Self-report scale that measures Social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety symptoms.


Secondary Outcome Measures :
  1. Subtle Avoidance Frequency Examination(SAFE) [ Time Frame: Change in safety behavior use from baseline to post treatment (4 weeks) and one month follow up (8 weeks) ]
    Self report scale used to assess how often people use safety behaviors to cope with their anxiety. Scores range from 33 to 165. Higher total scores are associated with more frequent safety behavior use.

  2. Cognitive and Affective Mindfulness Scale-Revised (CAMS-R) [ Time Frame: Change in mindfulness from baseline to post treatment (4 weeks) and one month follow up (8 weeks) ]
    Self-report used to measure mindfulness, including awareness of thoughts and feelings. Total scores range from 12 to 48 with higher scores indicating a greater ability to be mindful, present in the moment, and aware of thoughts and feelings.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Social Phobia Inventory score > 29

Exclusion Criteria:

  • receiving therapy
  • changes in the past 4 weeks with medication for emotional difficulties
  • psychotic symptoms

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03562650


Locations
Layout table for location information
United States, Florida
Florida State University, Department of Psychology
Tallahassee, Florida, United States, 32306
Sponsors and Collaborators
Florida State University
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Jesse Cougle, Associate Professor, Florida State University
ClinicalTrials.gov Identifier: NCT03562650    
Other Study ID Numbers: 2017.22461
First Posted: June 19, 2018    Key Record Dates
Last Update Posted: January 29, 2021
Last Verified: January 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Anxiety Disorders
Mental Disorders